Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14409
Articles
Drug
ICT’s GCC19CART Enters US Phase I Study for Colorectal Cancer
February 14, 2025
Drug
BRL Medicine’s BRL-101 Receives Clinical Trial Approval for Beta-Thalassemia
February 14, 2025
Company
Legal / IP
GenScript Biotech Sues Former CSO Fan Xiaohu for Trade Secret Infringement
February 14, 2025
Company
Drug
Innovent Biologics Initiates Phase I Study of IBI311 for Thyroid-Associated Ophthalmopathy
February 14, 2025
Company
Digital
Baidu Health’s Precision Matching Engine Powers Public Hospitals
February 14, 2025
Company
WuXi Biologics’ Revenues Surge 63.5% in H1 2022 on Strong CRDMO Growth
February 14, 2025
Company
Deals
MingMed Biotech’s Hong Kong IPO Signals Push for First-in-Class Drugs
February 14, 2025
Company
Drug
Junshi Biosciences’ JunMaiKang Biosimilar Gets NMPA Approval Filing
February 14, 2025
Company
Deals
Applied Protein Technology Raises Hundreds of Millions in Series B Funding
February 15, 2025
Company
Deals
SciClone Licenses Menarini’s Vaborem to Tackle Drug-Resistant Infections in China
February 15, 2025
Company
Drug
Zelgen Biopharmaceuticals’ ZGGS18 Receives NMPA Approval for Solid Tumor Treatment
February 15, 2025
Company
Deals
Fortune Care Raises Hundreds of Millions in Series B for Elderly Care Expansion
February 15, 2025
1
2
…
1,150
1,151
1,152
1,153
1,154
…
1,200
1,201
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?